Oxidative stress in the pathogenesis of preeclampsia

Proceedings of the Society for Experimental Biology and Medicine

Volumn 222, Issue 3, 1999, Pages 222-235

  Hubel, Carl A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; FREE RADICAL; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE;

ATHEROGENESIS; BLOOD VESSEL REACTIVITY; CONFERENCE PAPER; DYSLIPIDEMIA; ENDOTHELIUM LESION; FEMALE; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; INFLAMMATION; OXIDATIVE STRESS; PLACENTA; PLACENTA CIRCULATION; PREECLAMPSIA; VASOSPASM;

EID: 0032724348     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.1999.d01-139.x     Document Type: Conference Paper

References (208)

1. Hauth JC, Cunningham FG. Preeclampsia-eclampsia. In: Lindheimer MD, Roberts JM, Cunningham FG, Eds. Chesley's Hypertensive Disorders in Pregnancy (2nd ed). Stamford, CT: Appleton & Lange, pp169-199, 1999.
2. Lindheimer MD, Roberts JM, Cunningham FG, Chesley L. Introduction, history, controversies, and definitions. In: Lindheimer MD, Roberts JM, Cunningham FG, Eds. Chesley's Hypertensive Disorders in Pregnancy (2nd ed). Stamford, CT: Appleton & Lange, pp3-41, 1999.
3. Meis P, Goldenberg R, Mercer B. The preterm prediction study: Risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol 179:562-567, 1998.
4. Friedman E, Neff R. Pregnancy outcome as related to hypertension, edema, and proteinuria. In: Lindheimer M, Katz A, Zuspan F, Eds. Hypertension in Pregnancy. New York: John Wiley & Sons, p13, 1976.
5. Roberts J. Pregnancy-related hypertension. In: Creasy R, Resnik R, Eds. Maternal Fetal Medicine. Philadelphia: W. B. Saunders, pp804-843, 1994.
6. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinatol 18:661-682, 1991.
7. Lindheimer M, Roberts J, Cunningham F, Eds. Chesley's Hypertensive Disorders in Pregnancy (2nd ed). Stamford, CT: Appleton & Lange, 1999.
8. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 163:1365-1366, 1990.
9. Taylor RN, Roberts JM. Endothelial cell dysfunction. In: Lindheimer MD, Roberts JM, Cunningham FG, Eds. Chesley's Hypertensive Disorders in Pregnancy (2nd ed). Stamford, CT: Appleton & Lange, pp395-429, 1999.
10. Roberts JM. Endothelial dysfunction in preeclampsia. Sem Reprod Endocrinol 16:5-15, 1998.
11. Redman CW. Current topic: Preeclampsia and the placenta. Placenta 12:301-308, 1991.
12. Cross JC. Trophoblast function in normal and preeclamptic pregnancy. Fetal Matern Med Rev 8:57-66, 1996.
13. Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications. Am J Obstet Gynecol 175:1365-1370, 1996.
14. Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of abberrant lipoprotein and fatty acid metabolism in preeclampsia. Br J Obstet Gynaecol 103:614-620, 1996.
15. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, McLaughlin MK. Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol 161:1025-1034, 1989.
16. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med 119:598-620, 1992.
17. Halliwell B, Chirico S. Lipid peroxidation: Its mechanism, measurement, and significance. Am J Clin Nutr 57:715S-725S, 1993.
18. Smith WL, Marnett LJ, DeWitt DL. Prostaglandin and thromboxane biosynthesis. Pharmacol Ther 49:153-179, 1991.
19. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 10:709-720, 1996.
20. Walsh SC. Lipid peroxidation in pregnancy. Hypertension Pregnancy 13:1-25, 1994.
21. Gutteridge JMC. Free radicals in disease processes: A compilation of cause and consequence. Free Radic Res 19:141-158, 1993.
22. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet 344:721-724, 1994.
23. Pryor WA, Godber SS. Noninvasive measure of oxidative stress status in humans. Free Radic Biol Med 10:177-184, 1991.
24. Puhl H, Waeg G, Esterbauer H. Methods to determine oxidation of low-density lipoproteins. In: Packer L, Ed. Methods in Enzymology. San Diego: Academic Press, pp425-441, 1994.
25. Venuto RC, Lindheimer MD. Animal models. In: Lindheimer MD, Roberts JM, Cunningham FG, Eds. Chesley's Hypertensive Disorders in Pregnancy (2nd ed). Stamford, CT: Appleton & Lange, pp487-515, 1999.
26. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 70:427-451, 1990.
27. Fisher KA, Lluger A, Spargo BH, Lindheimer MD. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis. Medicine 60:267-276, 1981.
28. McCartney CP, Spargo BH, Larincz AB, Lefebure Y, Newton RE. Renal structure and function in pregnant patients with acute hypertension. Am J Obstet Gynecol 90:579-590, 1964.
29. Spargo B, McCartney C, Winemuller R. Glomerular capillary endotheliosis in toxemia of pregnancy. Arch Pathol 68:593-599, 1959.
30. Pollak V, Nettles J. The kidney in toxemia of pregnancy: A clinical and pathologic study based on renal biopsies. Medicine 39:469-477, 1960.
31. Knock GA, Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 175:1668-1674, 1996.
32. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, Umans JG. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest 101:464-470, 1998.
33. Nisell H, Hjemdahl P, Line B. Cardiovascular responses to circulating catecholamines in normal pregnancy and pregnancy-induced hypertension. Clin Physiol 5:479-493, 1985.
34. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 52:2682-2689, 1973.
35. Belfort MA, Saade GR. Retinal vasospasm associated with visual disturbance in preeclampsia: Color flow doppler findings. Am J Obstet Gynecol 169:523-525, 1993.
36. Valluri S, Adelberg DA, Curtis RS, Olk RJ. Diagnostic indocyanine green angiography in preeclampsia. Am J Ophthalmol 122:672-677, 1996.
37. Krauss T, Juhn W, Lakoma C, Augustin HG. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 177:443-449, 1997.
38. Taylor RN, Crombleholme WR, Friedman SA, Jones LA, Casal DC, Roberts JM. High plasma cellular, fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 165:895-901, 1991.
39. Davidge ST, Signorella AP, Hubel CA, Lykins DL, Roberts JM. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension 28:758-764, 1996.
40. Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small low-density lipoproteins and vascular cell adhesion molecule (VCAM-1) are increased in association with hyperlipidemia in preeclampsia. Metabolism 47:1281-1288, 1998.
41. Haller H, Hempel A, Homuth V, Mandelkow A, Busjahn A, Maasch C, Drab M, Lindschau C, Jupner A, Vetter K, Dudenhausen J, Luft FC. Endothelial-cell permeability and protein kinase C in preeclampsia. Lancet 351:945-949, 1998.
42. Chwalisz K, Buhimschi I, Garfield RE. Role of nitric oxide in obstetrics. Prenat Neonat Med 1:292-328, 1996.
43. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 171:944-948, 1994.
44. Davidge S, Stranko C, Roberts J. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 174:1008-1013, 1996.
45. Nobunaga T, Tokugawa Y, Hashimoto K, Kimura T, Matsuzaki N, Nitta Y, Fujita T, Kidoguchi K, Azuma C, Saji F. Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest 41:189-193, 1996.
46. Smarason A, Allman K, Young D, Redman C. Women with preeclampsia have elevated levels of serum nitrate, a stable end product of nitric oxide. Br J Obstet Gynaecol 104:538-543, 1997.
47. Ranta V, Viinikka L, Halmesmaki E, Ylikorkala O. Nitric oxide production with preeclampsia. Obstet Gynecol 93:442-445, 1999.
48. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol 41:R441-R463, 1997.
49. Page EW. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of preeclampsia. Am J Obstet Gynecol 37:291-293, 1939.
50. Shembrey M, Noble A. An instructive case of abdominal pregnancy. Aust NZJ Obstet Gynaecol 35:220-221, 1995.
51. Piering WF, Garancis JG, Becker CG, Beres JA, Lemann J. Preeclampsia related to a functioning extrauterine placena: Report of a case and 25-year follow-up. Am J Kidney Dis 21:310-313, 1993.
52. Fisher SJ, Roberts JM. Defects in placentation and placental perfusion. In: Lindheimer MD, Roberts JM, Cunningham FG, Eds. Chesley's Hypertensive Disorders in Pregnancy (2nd ed). Stamford, CT: Appleton & Lange, pp377-394, 1999.
53. Pijnenborg R. The placental bed. Hypertension Pregnancy 15:7-23, 1996.
54. Brosens IA. Morphological changes in the uteroplacental bed in pregnancy hypertension. Clin Obstet Gynecol 77:573-593, 1977.
55. Sheppard BL, Bonnar J. An ultrastructural study of uteroplacental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 88:695-705, 1981.
56. Lunell NO, Lewander R, Mamoun I, Nylund L, Sarby S, Thornstrom S. Uteroplacental blood flow in pregnancy-induced hypertension. Scand J Clin Lab Invest 44:28-35, 1984.
57. Trudinger BJ, Giles WD, Cook CM, Bombarderi J, Collins L. Fetal umbilical artery flow velocity waveforms and placental resistance: Clinical significance. Br J Obstet Gynaecol 92:23-30, 1985.
58. Wigglesworth JS. Morphologic variations in the insufficient placenta. J Obstet Gynecol 71:871-884, 1964.
59. Chesley LC. Hypertensive Disorders of Pregnancy. New York: Appleton-Century-Crofts, pp460-461, 1978.
60. Tominaga T, Page EW. Accommodation of the human placenta to hypoxia. Am J Obstet Gynecol 94:679-685, 1966.
61. Zamudio S, Palmer SK, Regensteiner JG, Moore LG. High altitude and hypertension during pregnancy. Am J Human Biol 7:183-193, 1995.
62. DeWolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 123:164-174, 1975.
63. Zeek P, Assali N. Vascular changes in the decidua associated with eclamptogenic toxemia. Am J Clin Pathol 20:1099-1109, 1950.
64. Fox H. Pathology of the Placenta. London: W. B. Saunders, pp213-237, 1978.
65. Hubel CA. Dyslipidemia, iron, and oxidative stress in preeclampsia: Assessment of maternal and feto-placental interactions. Sem Reprod Endocrinol 16:75-92, 1998.
66. Staff AC, Ranheim T, Khoury J, Henriksen T. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol 180:587-592, 1999.
67. Magann E, Martin J, Isaacs J, Perry K, Martin R, Meydrech E. Immediate postpartum curettage: Accelerated recovery from severe preeclampsia. Obstet Gynecol 81:502-506, 1993.
68. 2α is elevated in decidua basalis in women with preeclampsia. Am J Obstet Gynecol (in press).
69. Roberts LJ, Morrow JD. The isoprostanes: Novel markers of lipid peroxidation and potential mediators of oxidant injury. Adv Prostaglandin Thromboxane Leukot Res 23:219-224, 1995.
70. Walsh SW, Wang Y. Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol 169:1462-1466, 1993.
71. Walsh SW, Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 80:1888-1893, 1995.
72. Walsh SW, Wang Y, Jesse R. Placental production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. Hypertension Pregnancy 15:101-111, 1996.
73. Walsh SW, Wang Y, Vaughan JE. Placental production of 8-isoprostane is significantly increased in preeclampsia. J Soc Gynecol Invest 4:96A, 1997.
74. Walsh SW, Wang Y. Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol 169:1456-1461, 1993.
75. Warso MA, Lands WE. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull 39:277-280, 1983.
76. Moncada S, Vane JR. The discovery of prostacyclin: A fresh insight into arachidonic acid metabolism. In: Kharasch N, Fried J, Eds. Biochemical Aspects of Prostaglandins. New York: Academic Press, pp155-177, 1997.
77. Wetzka B, Charnock-Jones DS, Viville B, Cooper JC, Nusing R, Zahradnik HP, Smith SK. Expression of prostacyclin and thromboxane syntheses in placenta and placental bed after preeclamptic pregnancies. Placenta 17:573-581, 1996.
78. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am J Physiol 271:C1424-C1437, 1996.
79. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375:81-88, 1994.
80. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 151:1250-1254, 1995.
81. Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta: Evidence of peroxynitrite formation and action. Hypertension 28:488-493, 1996.
82. Lyall F, Gibson JL, Greer IA, Brockman DE, Eis AL, Myatt L. Increased nitrotyrosine in the diabetic placenta: Evidence for oxidative stress. Diabetes Care 21:1753-1758, 1998.
83. Kimura E, Kosaka H, Shiga T, Yoshimine T, Hayakawa T. Elevation of plasma nitric oxide end products during focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab 14:487-191, 1994.
84. Kooy NW, Royall JA. Agonist-induced peroxynitrite production from endothelial cells. Arch Biochem Biophys 310:352-359, 1994.
85. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411:157-160, 1997.
86. Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia revisited. Am J Obstet Gynecol 174:288-291, 1996.
87. Kirschner RE, Fantini GA. Role of iron and oxygen-derived free radicals in ischemia-reperfusion injury. J Am Coll Sur 179:103-117, 1994.
88. Zhang Z, Blake DR, Stevens CR, Kanczler JM, Winyard PG, Symons MC, Benboubetra M, Harrison R. A reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: The role of NADH as an electron donor. Free Radic Res 28:151-164, 1998.
89. Many A, Westerhausen-Larson A, Kanbour-Shakir A, Roberts JM. Xanthine oxidase/dehydrogenase is present in human placenta. Placenta 17:361-365, 1996.
90. Many A, Friedman SA, Hubel CA, Roberts JM. Xanthine oxidase activity in preeclamptic women is higher in invasive but not villous trophoblast. J Soc Gynecol Invest 3:36A, 1996.
91. Takehara Y, Yoshioka T, Sasaki J. Changes in the levels of lipoperoxide and antioxidant factors in human placenta during gestation. Acta Med Okayama 44:103-111, 1990.
92. Sekiba K, Yoshioka T. Changes of lipid peroxidation and superoxide dismutase activity in the human placenta. Am J Obstet Gynecol 135:368-371, 1979.
93. Poranen AK, Ekblad U, Uotila P, Ahotupa M. Lipid peroxidation and antioxidants in normal and preeclamptic pregnancies. Placenta 17:401-105, 1996.
94. Pandey S, Gujrati VR, Chandravati Sanger KC, Shanker K. Status of human placental lipid peroxidation, superoxide dismutase, and catalase during pregnancy-induced hypertension (PIH). Asia Pac J Pharmacol 10:41-44, 1995.
95. Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Invest 3:179-184, 1996.
96. Myatt L, Eis AL, Brockman DE, Kossenjans W, Greer IA, Lyall F. Differential localization of superoxide dismutase isoforms in placental villous tissue of normotensive, preeclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem 45:1433-1438, 1997.
97. Chen G, Wilson R, Boyd P, McKillip JH, Leitch C, Walker JJ, Burdon RH. Normal superoxide dismutase (SOD) gene in pregnancy-induced hypertension: Is the decreased SOD activity a secondary phenomenon? Free Radic Res 21:59-66, 1994.
98. Wisdom SJ, Wilson R, McKillip JH, Walker JJ. Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol 165:1701-1704, 1991.
99. Lefer DJ, Scalia R, Campbell B, Nossuli T, Hayward R, Salamon M, Grayson J, Lefer AM. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 99:684-691, 1997.
100. Roggensack A, Zhang Y, Davidge S. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 33:83-89, 1999.
101. Garzetti GG, Tranquilli AL, Cugini AM, Mazzanti L, Cester N, Romanini C. Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia. Obstet Gynecol 81:337-340, 1993.
102. Morris JM, Gopaul NK, Endresen MJ, Knight M, Linton EA, Dhir S, Änggard EE, Redman CW. Circulating markers of oxidative stress are raised in normal pregnancy and preeclampsia. Br J Obstet Gynaecol 105:1195-1199, 1998.
103. Wang Y, Walsh SW, Guo J, Zhang J. Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol 165:1690-1694, 1991.
104. Davidge ST, Hubel CA, Brayden RD, Capeles EC, McLaughlin MK. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 79:897-901, 1992.
105. Lorentzen B, Drevon CA, Endressen MJ, Henriksen T. Fatty acid pattern of esterfied and free fatty acids in sera of women with normal and preeclamptic pregnancy. Br J Obstet Gynaecol 102:530-537, 1995.
106. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 54:11135-11185, 1991.
107. Berliner JA, Heinecke JA. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20:707-727, 1996.
108. Jansen H, Ghanem H, Kuypers JH, Birkenhager JC. Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B. Atherosclerosis 115:255-262, 1995.
109. Armstrong VW, Wieland E, Diedrich F, Renner A, Rath W, Kreuzer H, Kuhn W, Oellerich M. Serum antibodies to oxidised low-density lipoprotein in preeclampsia and coronary heart disease. Lancet 343:1570, 1994.
110. Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL. Preeclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet 343:645-646, 1994.
111. Uotila J, Solakivi T, Jaakkola O, Tuimala R, Lehtimaki T. Antibodies against copper-oxidised and mondialdehyde-modified low-density lipoproteins in preeclamptic pregnancies. Br J Obstet Gynaecol 105:1113-1117, 1998.
112. Kurki T, Ailus K, Palosuo T, Ylikorkala O. Oxidized low-density lipoprotein, cardiolipin, and phosphatidyl serine fail to predict the risk of preeclampsia. Hypertension Pregnancy 15:251-256, 1996.
113. Basu TK, Schorah CJ. Vitamin C in Health and Disease. Westport, CT: AVI Publishing Co., pp95-100, 1982.
114. Clemetson CA, Andersen L. Ascorbic acid metabolism in preeclampsia. Obstet Gynecol 24:774-782, 1964.
115. Mikhail MS, Anyaegbunam A, Garfinkel D, Palan PR, Basu J, Romney SL. Preeclampsia and antioxidant nutrients: Decreased plasma levels of reduced ascorbic acid, α-tocopherol, and β-carotene in women with preeclampsia. Am J Obstet Gynecol 171:150-157, 1994.
116. Hubel CA, Kagan VE, Kisin ER, McLaughlin MK, Roberts JM. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: Implications for oxidative stress. Free Radic Biol Med 23:597-609, 1997.
117. Traber MG. Determinants of plasma vitamin E concentrations. Free Radic Biol Med 16:229-239, 1994.
118. Schiff E, Friedman SA, Stampfer M, Kao L, Barrett PH, Sibai BM. Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 175:1024-1028, 1996.
119. Uotila JT, Tuimala RJ, Aarnioi TM, Pyykko KA, Ahotupa MO. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. J Obstet Gynecol 100:270-276, 1993.
120. Hubel CA. Plasma vitamin E in preeclampsia. Am J Obstet Gynecol 177:484-485, 1977.
121. Buettner TGR, Jurkiewicz BA. Chemistry and biochemistry of ascorbic acid. In: Cadenas E, Packer L, Eds. Handbook of Antioxidants: Antioxidants in Health and Disease. New York: Marcel Dekker, Inc., pp91-115, 1996.
122. Tyurin VA, Borisenko GG, Fabisiak JP, Hubel CA, McLaughlin MK, Roberts JM, Kagan VE. Elevations in chelatable, redox-active copper contribute to increased ascorbate oxidation in plasma from women with preeclampsia. (abstract). J Soc Gynecol Invest 6(Suppl 1):169A, 1999.
123. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Sem Reprod Endocrinol 16:93-104, 1998.
124. Lorentzen B, Henriksen T. Plasma lipids and vascular dysfunction in preeclampsia. Sem Reprod Endocrinol 16:33-39, 1998.
125. Kaaja R. Insulin resistance syndrome in preeclampsia. Sem Reprod Endocrinol 16:41-46, 1998.
126. Reaven GM. Syndrome X: 6 years later. J Intern Med 236:13-22, 1994.
127. Herrera E, Lasuncion MA, Coronado DG, Aranda P, Luna PLO, Maier I. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am J Obstet Gynecol 158:1575-1583, 1988.
128. Knopp RH, Bonet B, Lasuncion MA, Montelongo A, Herrera E. Lipoprotein metabolism in pregnancy. In: Herrera E, Knopp R, Eds. Perinatal Biochemistry. Boca Raton, FL: CRC Press, Inc., pp20-51, 1992.
129. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 133:165-170, 1979.
130. Alvarez JJ, Montelongo A, Iglesias A, Lasuncion MA, Herrera E. Longitudinal study on lipoprotein profile, high-density lipoprotein subclass, and postheparin upases during gestation in women. J Lipid Res 37:299-308, 1996.
131. Coleman RA. The role of the placenta in lipid metabolism and transport. Sem Perinatol 13:180-191, 1989.
132. Bonet B, Brunzell JD, Gown AM, Knopp RH. Metabolism of very low density lipoprotein triglyceride by human placental cells: The role of lilpoprotein lipase. Metabolism 41:596-603, 1992.
133. Hubel CA, McLaughloin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours postpartum. Am J Obstet Gynecol 174:975-982, 1996.
134. Lorentzen B, Endresen MJ, Calusen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertension Pregnancy 13:103-109, 1994.
135. Gratacos E, Casals E, Sanllehy C, Cararach V, Alonso PL, Fortuny A. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand 75:896-901, 1996.
136. Sattar N, Bedomir A, Berry C, Shepherd J, Greer Iak, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: Pathogenic parallels to atherosclerosis. Obstet Gynecol 89:403-108, 1997.
137. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 85:353-356, 1995.
138. Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR, Llupien PJ, Despres JP. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279:1955-1961, 1998.
139. Krauss RM. Genetic, metabolic, and dietary influences on the atherogenic lipoprotein phenotype. In: Simopoulos AP, Nestel PJ, Eds. Genetic Variation and Dietary Response: World Review of Nutrition and Dietetics. Basel, Switzerland: Karger, Vol 80:pp2-43, 1997.
140. Lewis GF, Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 12:37-56, 1996.
141. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276:882-888, 1996.
142. Anber R, Griffin BA, McConnell M, Packard CJ, Shepherd J. Influence of plasma lipid and LDL-subfraction profile on the interaction between low-density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 124:261-271, 1996.
143. Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 94:350-356, 1993.
144. Weisser B, Locher R, deGraff J, Moser R, Sachinidis A. Low-density lipoprotein subfractions increase thromboxane formation in endothelial cells. Biochem Biophys Res Commun 192:1245-1250, 1993.
145. i in vascular smooth muscle cells. Circ Res 73:118-124, 1993.
146. Hubel CA, Shakir Y, Gallaher MJ, McLaughlin MK, Roberts JM. Low-density lipoprotein particle size decreases during normal pregnancy in association with triglyceride increases. J Soc Gynecol Invest 5:244-250, 1998.
147. Chesley LC. Hypertension in pregnancy: Definitions, familial factor, and remote prognosis. Kidney Int 18:234-240, 1980.
148. Arngrimsson R, Geirsson RT, Bjornsson S, Bjornsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and preeclampsia in a defined population. Br J Obstet Gynaecol 97:762-769, 1990.
149. Cooper DW, Brennecke SP, Wilton AN. Genetics of preeclampsia. Hypertension Pregnancy 12:1-23, 1993.
150. Ward K, Linheimer MD. Genetic factors. In: Lindheimer MD, Roberts JM, Cunningham FG, Eds. Chesley's Hypertensive Disorders in Pregnancy (2nd ed). Stamford, CT: Appleton & Lange, pp431-452, 1999.
151. Arngrimsson R, Bjornsson H, Geirsson RT. Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. Hypertension Pregnancy 14:27-38, 1995.
152. Hubel CA, Roberts JM, Ferrell RE. Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene. Clinical Genetics (in press).
153. Fisher RM, Humphries SE, Talmud PJ. Common variation in the lipoprotein lipase gene: Effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 135:145-159, 1997.
154. Hokanson JE, Brunzell JD, Jarvik GP, Sijsman EM, Austin MA. Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency. Am J Hum Genet 64:608-618, 1999.
155. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340:9-13, 1999.
156. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Cand 74:772-776, 1995.
157. Hubel CA, Snaedal S, Geirsson RT, Roberts JM, Arngrimsson R. Women with a history of eclampsia manifest dyslipidemia during later life (abstract). J Soc Gynecol Invest 5(Suppl 1):40A, 1998.
158. Bonet B, Chait A, Gown AM, Knopp RH. Metabolism of modified LDL by cultured human placental cells. Atherosclerosis 112:125-136, 1995.
159. Casasco A, Calligaro A, Casasco M, Tateo S, Icaro Cornaglia A, Reguzzoni M, Farina A. Immunohistochemical localization of lipoperoxidation products in normal human placenta. Placenta 18:249-253, 1997.
160. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 57:779S-786S, 1993.
161. Morris J, Endresen MJ, Watts A, Linton E, Redman CW. Preeclamptic placental syncytiotrophoblast microvillous membranes have altered fluidity and inhibit endothelial cell proliferation (abstract). Hypertension Pregnancy 16:78, 1996.
162. Smarason AK, Sargent IL, Starkey PM, Redman CW. The effect of placental syncytiotrophoblast microvillous membranes from normal and preeclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 100:943-949, 1993.
163. Cockell AP, Learmont JG, Smarason AK, Redman CW, Sargent IL, Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 104:235-240, 1997.
164. Murai JT, Muzykanskiy E, Taylor RN. Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism 46:963-967, 1997.
165. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 82:1582-1588, 1997.
166. Toborek M, Barger W, Mattson MP, Barve S, McClain CJ, Hening B. Linoleic acid and TNF-α cross-amplify oxidative injury and dysfunction of endothelial cells. J Lipid Res 37:123-135, 1996.
167. Stark JM. Preeclampsia and cytokine-induced oxidative stress. Br J Obstet Gynaecol 100:105-109, 1993.
168. Hotamisligil GS, Arner P, Cro JF, Atkinson RL, Speigelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995.
169. Kern PA, Saghizadeh M, Ong JM, Bosch PJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue: Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995.
170. Redman C, Sacks G, Sargent I. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180:499-506, 1999.
171. Sacks GP, Studena K, Sargent II, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 179:80-86, 1998.
172. Butterworth BH, Green IA, Liston WA, Haddad NG, Johnston TA. Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension. Br J Obstet Gynaecol 98:929-933, 1991.
173. Greer IA, Dawes J, Johnston TA, Calder AA. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet Gynecol 78:28-32, 1991.
174. Johnston TA, Greer IA, Dawes J, Calder AA. Neutrophil activation in small for gestational age pregnancies. Br J Obstet Gynaecol 98:978-982, 1989.
175. Greer IA, Leask R, Hodson BA, Dawes J, Kilpatrick DC, Liston WA. Endothelin, elastase, and endothelial dysfunction in preeclampsia. Lancet 337:558, 1991.
176. Hazen SL, Hsu FF, Mueller DM, Crowley JR, Heinecke JW. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 98:1283-1289, 1996.
177. Hansen PR, Stawski G. Neutrophil-mediated damage to isolated myocytes after anoxia and reoxygenation. Cardiovasc Res 28:565-569, 1994.
178. Hardy SJ, Ferrante A, Poulos A, Robinson BS, Johnson DW, Murray AW. Effect of exogenous fatty acids with greater than 22 carbon atoms (very long chain fatty acids) on superoxide production by human neutrophils. J Immunol 153:1754-1761, 1994.
179. Pronai L, Hiramatsu K, Saigusa Y, Nakazawa H. Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes. Atherosclerosis 90:39-47, 1991.
180. Gorog P. Activation of human blood monocytes by oxidized poly-unsaturated fatty acids: A possible mechanism for the generation of lipid peroxides in the circulation. Int J Exp Pathol 72:227-237, 1991.
181. Maeba R, Maruyama A, Tarutani O, Uea N, Shimasaki H. Oxidized low-density lipoprotein induces the production of superoxide by neutrophils. FEBS Lett 377:309-312, 1995.
182. Uhlinger DJ, Burnham DN, Mullins RE, Kalmar JR, Culter CW, Arnold RR, Lambeth JD, Merrill AH. Functional differences in human neutrophils isolated pre- and postprandially. FEBS Lett 286:28-32, 1991.
183. Hoogerbrugge N, Verkerk A, Jacobs ML, Postema PTE, Jongkind JF. Hypertriglyceridemia enhances monocyte binding to endothelial cells in NIDDM. Diabetes Care 19:1122-1125, 1996.
184. Griendling KK, Ushio-Fukai M. NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med 7:301-307, 1997.
185. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 32:488-495, 1998.
186. 1 receptor. J Clin Invest 103:945-952, 1999.
187. Cutler MG, Schneider R. Linoleate oxidation products and cardiovascular lesions. Atherosclerosis 20:383-394, 1974.
188. Yoshioka T, Ichikawa L, Fogo A. Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 2:902-912, 1991.
189. Stamler FW. Fatal eclamptic disease of pregnant rats fed anti-vitamin E stress diet. Am J Pathol 35:1207-1231, 1959.
190. 2+-dependent retraction of vascular smooth muscle cells. Circ Res 79:871-880, 1996.
191. Hubel CA, Davidge ST, McLaughlin MK. Lipid hydroperoxides potentiate mesenteric artery vasoconstrictor responses. Free Radic Biol Med 14:397-407, 1993.
192. Galle J, Ochslen M, Schollmeyer P, Wanner C. Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Hypertension 23:556-564, 1994.
193. Simon BC, Cunningham LD, Cohen RA. Oxidized low-density lipoproteins cause contraction and inihibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 86:75-79, 1990.
194. Remuzzi G, Marchesi D, Zoja C, Muratore D, Mecca G, Misiani R, Rossi E, Barbato M, Capetta P, Donati MB, Gaetano GD. Reduced umbilical and placental vascular prostacyclin in severe preeclampsia. Prostaglandins 20:105-110, 1980.
195. Falanga A, Doni MG, Delaini F. Unbalanced control of TxA2 and PGI2 synthesis in vitamin E-deficient rats. Am J Physiol 245:H867-H870, 1983.
196. Peters JH, Ginsberg MH, Bohl BP, Sklar LA, Cochrane CG. Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung. J Clin Invest 78:1596-1603, 1986.
197. Baker PN, Davidge ST, Roberts JM. Plasma from patients with preeclampsia increases endothelial cell nitric oxide production. Hypertension 26:244-248, 1995.
198. Davidge ST, Baker PN, Roberts JM. NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am J Physiol 269:H1106-H1112, 1995.
199. Fries DM, Penha RG, D'Amico EA, Abdalla DS, Monteiro HP. Oxidized low-density lipoprotein stimulates nitric oxide release by rabbit aortic endothelial cells. Biochem Biophys Res Commun 207:231-237, 1995.
200. Hirata K, Miki N, Kuroda Y, Sakoda T, Kawashima S, Yokoyama M. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res 76:958-962, 1995.
201. Baker PN, Davidge ST, Barankiewicz J, Roberts JM. Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension 27:56-61, 1996.
202. Myers DE, Huang WN, Larkins RG. Lipoprotein-induced prostacyclin production in endothelial cells and effects of lipoprotein modification. Am J Physiol 271:C1504-C1511, 1996.
203. Wang J, Zhen E, Guo Z, Lu Y. Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: Protective effect of antioxidants. Free Radic Biol Med 7:243-249, 1989.
204. Spickett C, Reglinski J, Smith W, Wilson R, Walker J, McKillop J. Erythrocyte glutathione balance and membrane stability during preeclampsia. Free Radic Biol Med 24:1049-1055, 1998.
205. Chiu D, Lubin B, Sohet SB. Peroxidative reactions in red cell biology. In: Pryor WA, Ed. Free Radicals in Biology. New York: Academic Press, pp115-120, 1982.
206. Nardulli G, Proverbio F, Limongi FG, Marin R, Proverbio T. Preeclampsia and calcium adenosine triphosphate activity of red blood cell ghosts. Am J Obstet Gynecol 171:1361-1365, 1994.
207. Kagan VE. Lipid Peroxidation in Biomembranes. Boca Raton, FL: CRC Press, Inc., pp55-117, 1988.
208. Cester N, Staffolani R, Rabini RA, Magnanelli R, Salvolini E, Galassi R, Mazzanti L, Romanini C. Pregnancy-induced hypertension: A role for peroxidation in microvillous plasma membranes. Mol Cell Biochem 131:151-155, 1994.